Data search
Results for MligTC455_24611
| Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|
| MligTC455_24611 | 321 | 6.69 | Mlig455_047928 | Neo: - Age: Up-Down-Up |
Mlig455_047928 {REF} {Length: 1394} {RNA1310_25335} {RNA815_17461} |
Cumulative graph for MligTC455_24611
Region-enriched expression
| Region | logFC | logCPM | Pvalue | FDR | Specificity |
|---|---|---|---|---|---|
| RegionR1 | -0.643 | 3.223 | 0.67760 | 1.00000 | |
| RegionR2 | 0.998 | 3.223 | 0.11336 | 0.41630 | |
| RegionR3 | 0.902 | 3.223 | 0.07902 | 0.49766 | |
| RegionR4 | 1.02 | 3.223 | 0.10275 | 0.31291 | |
| RegionR5 | -0.21 | 3.223 | 0.70815 | 1.00000 | |
| RegionR6 | 0.688 | 3.223 | 0.20073 | 0.77244 | |
| RegionR7 | -0.825 | 3.223 | 0.31113 | 0.94504 | |
| RegionR8 | -1.93 | 3.223 | 0.11363 | 0.62393 |
Regeneration-enriched expression
| Region | logFC | logCPM | PValue | FDR | Specificity |
|---|---|---|---|---|---|
| RegenerationR1 | -6.19 | 3.223 | 0.22068 | 0.95534 | |
| RegenerationR2 | -1.704 | 3.223 | 0.00112 | 0.04976 | |
| RegenerationR3 | -1.266 | 3.223 | 0.02216 | 0.27010 | |
| RegenerationR4 | -0.831 | 3.223 | 0.15680 | 0.58820 | |
| RegenerationR5 | -0.269 | 3.223 | 0.64354 | 0.92917 | |
| RegenerationR6 | -1.247 | 3.223 | 0.03612 | 0.23781 | |
| RegenerationBL | 0.41 | 3.223 | 0.59576 | 0.94427 | |
| RegenerationTP | 0.711 | 3.223 | 0.45897 | 0.87324 |
Genes with expression patterns similar to MligTC455_24611
| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | MligTC455_24611 | 321 | 6.69 | Mlig455_047928 | Neo: - Age: Up-Down-Up |
6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_047928 {REF} {Length: 1394} {RNA1310_25335} {RNA815_17461} | |
| 2. | MligTC455_42421 | 451 | 9.4 | Mlig455_014113 | Neo: - Age: - |
1.709 | - | - | - | 0.757 | - | 0.952 | Mlig455_014113 {REF} {Length: 3365} {RNA1509_22432} {RNA1310_7691.1, RNA1509_22432} {RNA1509_22432, RNA815_2712.1} | |
| 3. | MligTC455_47951 | 205 | 4.27 | Mlig455_070893 | Neo: - Age: - |
GRID2IP | 0.969 | - | - | - | - | - | 0.969 | Mlig455_070893 {REF} {Length: 3502} {Pfam: PDZ domain [PF00595.26, score=40.9]; PDZ domain [PF17820.3, score=32.7]; PDZ domain [PF13180.8, score=22.9]; RhoGEF domain [PF00621.22, score=18.8]} {Human: ENSG00000215045, GRID2IP, Grid2 interacting protein, [Score=57.4, Expect=7e-08]} {Mouse: ENSMUSG00000022580, Rhpn1, rhophilin, Rho GTPase binding protein 1, [Score=50.4, Expect=7e-06]; ENSMUSG00000010825, Grid2ip, glutamate receptor, ionotropic, delta 2 (Grid2) interacting protein 1, [Score=50.1, Expect=1e-05]} {Dmel: FBgn0264598, PsGEF, Protostome-specific GEF, [Score=78.2, Expect=2e-14]} {Smed: dd_Smed_v6_12613_0_1, dd_Smed_v6_12613_0_1, [Score=55.8, Expect=5e-08]} {RNA1509_38079} {RNA1310_16413, RNA1509_38079} {RNA1509_38079, RNA815_31333} |
| 4. | MligTC455_14229 | 116 | 2.42 | Mlig455_067075 | Neo: - Age: - |
0.963 | - | - | - | - | - | 0.963 | Mlig455_067075 {REF} {Length: 1955} {RNA1509_33166} {RNA1310_13794.1} {RNA815_5286} | |
| 5. | MligTC455_19193 | 147 | 3.07 | Mlig455_007213 | Neo: - Age: - |
BFAR | 0.963 | - | - | - | - | - | 0.963 | Mlig455_007213 {REF} {Length: 2792} {Pfam: Zinc finger, C3HC4 type (RING finger) [PF13920.8, score=31.1]; Zinc finger, C3HC4 type (RING finger) [PF13923.8, score=30.1]; Zinc finger, C3HC4 type (RING finger) [PF00097.27, score=30.0]; zinc finger of C3HC4-type, RING [PF15227.8, score=29.7]; RING-type zinc-finger [PF13445.8, score=29.4]; Ring finger domain [PF13639.8, score=27.0]; zinc-RING finger domain [PF14634.8, score=25.5]; Prokaryotic RING finger family 4 [PF14447.8, score=22.2]; RING-H2 zinc finger domain [PF12678.9, score=19.9]} {Human: ENSG00000275618, BFAR, bifunctional apoptosis regulator, [RH, Score=49.3, Expect=7e-07]; ENSG00000103429, BFAR, bifunctional apoptosis regulator, [RH, Score=49.3, Expect=7e-07]} {Mouse: ENSMUSG00000022684, Bfar, bifunctional apoptosis regulator, [RH, Score=52.8, Expect=1e-08]; ENSMUSG00000057596, Trim30d, tripartite motif-containing 30D, [RH, Score=50.8, Expect=2e-07]} {Smed: dd_Smed_v6_10019_0_1, dd_Smed_v6_10019_0_1, [Score=46.2, Expect=2e-06]} {RNA1509_42543, RNA1509_53684} {RNA1310_39360, RNA1509_42543} {RNA1509_42543, RNA815_20181} |
| 6. | MligTC455_27561 | 28353 | 590.69 | Mlig455_068574 | Neo: - Age: logFC(26M/2M)=-0.350 |
TPT1 | 0.957 | - | - | - | - | - | 0.957 | Mlig455_068574 {REF} {Length: 1149} {Pfam: Translationally controlled tumour protein [PF00838.19, score=222.5]} {Human: ENSG00000133112, TPT1, tumor protein, translationally-controlled 1, [RH, Score=182, Expect=1e-58]} {Mouse: ENSMUSG00000060126, Tpt1, tumor protein, translationally-controlled 1, [RH, Score=180, Expect=4e-58]} {Dmel: FBgn0037874, Tctp, Translationally controlled tumor protein, [RH, Score=154, Expect=7e-48]} {Celegans: WBGene00009122, tct-1, Translationally-controlled tumor protein homolog, [RH, Score=106, Expect=2e-29]} {Smed: dd_Smed_v6_136_0_1, dd_Smed_v6_136_0_1, [RH, Score=196, Expect=9e-65]} {RNA1509_10057, RNA1509_1294, RNA1509_5625, RNA1509_796} {RNA1310_26303.1, RNA1509_10057, RNA1509_1294, RNA1509_796} {RNA1509_10057, RNA1509_1294, RNA1509_796, RNA815_881.1} |
| 7. | MligTC455_42142 | 732 | 15.25 | Mlig455_042093, Mlig455_065827 | Neo: - Age: - Region-enriched R5: 1.672/0.02833 |
EHHADH | 0.957 | - | - | - | - | 0.957 | - | Mlig455_042093 {REF} {Length: 1658} {Pfam: 3-hydroxyacyl-CoA dehydrogenase, NAD binding domain [PF02737.20, score=123.4]; Zinc finger, C3HC4 type (RING finger) [PF13920.8, score=50.6]; NAD binding domain of 6-phosphogluconate dehydrogenase [PF03446.17, score=29.9]; Prokaryotic RING finger family 4 [PF14447.8, score=22.4]; Ring finger domain [PF13639.8, score=21.2]; NAD-dependent glycerol-3-phosphate dehydrogenase N-terminus [PF01210.25, score=20.1]; NADP oxidoreductase coenzyme F420-dependent [PF03807.19, score=19.4]} {Human: ENSG00000113790, EHHADH, enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase, [Score=67.8, Expect=5e-12]} {Mouse: ENSMUSG00000022853, Ehhadh, enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase, [Score=73.9, Expect=3e-14]} {Dmel: FBgn0028479, Mtpalpha, Mitochondrial trifunctional protein alpha subunit, [Score=50.4, Expect=1e-06]} {Celegans: WBGene00007129, B0272.3, Probable 3-hydroxyacyl-CoA dehydrogenase B0272.3, [Score=68.2, Expect=6e-13]} {Smed: dd_Smed_v6_725_0_2, dd_Smed_v6_725_0_2, [Score=60.8, Expect=2e-10]} {RNA1509_20505, RNA1509_29455} {RNA1310_21714, RNA1509_20505, RNA1509_29455} {RNA1509_20505, RNA1509_29455, RNA815_13816} Mlig455_065827 {REF} {Length: 1494} {Pfam: 3-hydroxyacyl-CoA dehydrogenase, NAD binding domain [PF02737.20, score=123.4]; Zinc finger, C3HC4 type (RING finger) [PF13920.8, score=50.6]; NAD binding domain of 6-phosphogluconate dehydrogenase [PF03446.17, score=29.9]; Prokaryotic RING finger family 4 [PF14447.8, score=22.4]; Ring finger domain [PF13639.8, score=21.2]; NAD-dependent glycerol-3-phosphate dehydrogenase N-terminus [PF01210.25, score=20.1]; NADP oxidoreductase coenzyme F420-dependent [PF03807.19, score=19.4]} {Human: ENSG00000113790, EHHADH, enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase, [Score=67.8, Expect=5e-12]} {Mouse: ENSMUSG00000022853, Ehhadh, enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase, [Score=73.9, Expect=4e-14]} {Dmel: FBgn0028479, Mtpalpha, Mitochondrial trifunctional protein alpha subunit, [Score=50.8, Expect=9e-07]} {Celegans: WBGene00007129, B0272.3, Probable 3-hydroxyacyl-CoA dehydrogenase B0272.3, [Score=68.2, Expect=6e-13]} {Smed: dd_Smed_v6_725_0_2, dd_Smed_v6_725_0_2, [Score=60.8, Expect=2e-10]} {RNA1509_20505} {RNA1310_21714} {RNA815_9491} |
| 8. | MligTC455_47235 | 232 | 4.84 | Mlig455_011474 | Neo: - |
UBASH3B | 0.957 | - | - | - | - | - | 0.957 | Mlig455_011474 {REF} {Length: 5904} {Pfam: Histidine phosphatase superfamily (branch 1) [PF00300.24, score=51.3]} {Human: ENSG00000154127, UBASH3B, ubiquitin associated and SH3 domain containing B, [RH, Score=153, Expect=2e-38]} {Mouse: ENSMUSG00000032020, Ubash3b, ubiquitin associated and SH3 domain containing, B, [RH, Score=169, Expect=5e-44]} {Dmel: FBgn0039137, CG13604, [RH, Score=120, Expect=5e-28]} {Celegans: WBGene00020321, T07F12.1, [RH, Score=116, Expect=1e-28]} {Smed: dd_Smed_v6_12024_0_1, dd_Smed_v6_12024_0_1, [RH, Score=162, Expect=4e-42]} {RNA1509_10245, RNA1509_37049} {RNA1310_4087.1, RNA1509_10245, RNA1509_37049} {RNA1509_10245, RNA1509_37049, RNA815_2334.1} |
| 9. | MligTC455_29693 | 81 | 1.69 | Mlig455_032201, Mlig455_036011, Mlig455_054134 | Neo: - |
ANKRD50 | 0.955 | - | - | - | - | - | 0.955 | Mlig455_032201 {REF} {Length: 3871} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=42.5]; Mab-21 protein [PF03281.16, score=40.7]; Ankyrin repeats (many copies) [PF13637.8, score=40.2]; Ankyrin repeats (many copies) [PF13857.8, score=39.0]; Ankyrin repeat [PF13606.8, score=34.3]; Ankyrin repeat [PF00023.32, score=30.5]} {Human: ENSG00000151458, ANKRD50, ankyrin repeat domain 50, [Score=65.9, Expect=2e-10]; ENSG00000170921, TANC2, tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, [Score=63.9, Expect=9e-10]} {Mouse: ENSMUSG00000044864, Ankrd50, ankyrin repeat domain 50, [Score=66.6, Expect=8e-11]} {Dmel: FBgn0041096, rols, rolling pebbles, [Score=60.8, Expect=3e-09]} {Celegans: WBGene00006616, trp-4, TRP (Transient receptor potential) channel family, [Score=55.5, Expect=2e-07]} {Smed: dd_Smed_v6_12936_0_1, dd_Smed_v6_12936_0_1, [Score=60.1, Expect=4e-09]} {RNA1509_27730} {RNA1310_21755.1} {RNA815_2426.1} Mlig455_036011 {REF} {Length: 1929} {Pfam: Mab-21 protein [PF03281.16, score=39.7]} {RNA1509_27730} {RNA1310_4721} {RNA815_5358.1} Mlig455_054134 {REF} {Length: 2699} {RNA1509_26281} {RNA1310_31514} {RNA815_5358.1} |
| 10. | MligTC455_25107 | 160 | 3.33 | Mlig455_002517, Mlig455_002651 | Neo: - Age: - |
GABRB2 | 0.952 | - | - | - | - | - | 0.952 | Mlig455_002517 {REF} {Length: 3630} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=169.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=153.0]} {Human: ENSG00000145864, GABRB2, gamma-aminobutyric acid type A receptor beta2 subunit, [RH, Score=414, Expect=6e-139]} {Mouse: ENSMUSG00000007653, Gabrb2, gamma-aminobutyric acid (GABA) A receptor, subunit beta 2, [RH, Score=408, Expect=5e-137]} {Dmel: FBgn0010240, Lcch3, Ligand-gated chloride channel homolog 3, [RH, Score=462, Expect=2e-158]} {Celegans: WBGene00001512, gab-1, Gamma-aminobutyric acid receptor subunit beta, [Score=458, Expect=2e-156]} {Smed: dd_Smed_v6_25116_0_1, dd_Smed_v6_25116_0_1, [RH, Score=484, Expect=5e-167]} {RNA1509_47435} {RNA1310_12876.1, RNA1509_47435} {RNA1509_47435, RNA815_12505} Mlig455_002651 {REF} {Length: 3208} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=169.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=153.8]} {Human: ENSG00000145864, GABRB2, gamma-aminobutyric acid type A receptor beta2 subunit, [RH, Score=413, Expect=6e-139]} {Mouse: ENSMUSG00000007653, Gabrb2, gamma-aminobutyric acid (GABA) A receptor, subunit beta 2, [RH, Score=408, Expect=5e-137]} {Dmel: FBgn0010240, Lcch3, Ligand-gated chloride channel homolog 3, [RH, Score=462, Expect=1e-158]} {Celegans: WBGene00001512, gab-1, Gamma-aminobutyric acid receptor subunit beta, [Score=459, Expect=7e-157]} {Smed: dd_Smed_v6_25116_0_1, dd_Smed_v6_25116_0_1, [RH, Score=484, Expect=5e-167]} {RNA1509_47435} {RNA1310_12876.1} {RNA815_12505} |